This inventor holds 3 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1977-1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Higashikurume, JA (1977)
- Higashikurume, JP (1978)
- Tokyo, JA (1978)
Company Filing History:
Years Active: 1977-1978
Title: Shigemi Kawahara: Innovator in Pharmaceutical Formulations
Introduction
Shigemi Kawahara is a notable inventor based in Higashikurume, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized oral formulations. With a total of three patents to his name, Kawahara's work has the potential to impact the medical community positively.
Latest Patents
Kawahara's latest patents include a stabilized oral prostaglandin formulation and a process for preparing stable prostaglandin E group-containing formulations. The first patent discloses a dry, stabilized oral pharmaceutical formulation containing a prostaglandin E group, which is prepared from a lyophilized composition. This composition includes a prostaglandin E group and at least one member selected from a thiol compound, dextrin, dextran, a lower alkyl cellulose, and a water-soluble salt of deoxycholic acid. The second patent provides a process for preparing a prostaglandin E group-containing formulation by adding to the prostaglandin E group at least one additive selected from thiol compounds, water-soluble high molecular weight compounds, and water-soluble salts of deoxycholic acid, followed by lyophilization.
Career Highlights
Kawahara is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in pharmaceutical formulations, enhancing the stability and efficacy of medications.
Collaborations
Kawahara has worked alongside notable colleagues such as Kiyoshi Okazaki and Masuo Murakami. Their collaborative efforts have fostered an environment of innovation and creativity within the pharmaceutical sector.
Conclusion
Shigemi Kawahara's contributions to the field of pharmaceuticals through his patents and collaborative work highlight his role as an influential inventor. His innovative formulations have the potential to improve patient outcomes and advance medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile